Robaxin-750 (methocarbamol recalls

The FDA has published 1 recall involving Robaxin-750 (methocarbamol since 2018. The latest was reported on 10 Oct 2018. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2018

Last 12 months0reported

Class I1100% of total

Ongoing0latest 10 Oct 2018

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 1 100%Class II 0 0%Class III 0 0%

Why robaxin-750 (methocarbamol is recalled

Other Reasons1100%

Companies

Endo Pharmaceuticals1100%

By year

20181100%

All robaxin-750 (methocarbamol recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
10 Oct 2018Drug	CLASS I	robaxin-750 (methocarbamol tablets, USP), 750 mg recalled	Endo Pharmaceuticals	Other	Nationwide

Should you stop taking Robaxin-750 (methocarbamol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.